317 related articles for article (PubMed ID: 18577547)
1. Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition.
Rowe JB; Hughes L; Ghosh BC; Eckstein D; Williams-Gray CH; Fallon S; Barker RA; Owen AM
Brain; 2008 Aug; 131(Pt 8):2094-105. PubMed ID: 18577547
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
3. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement.
Monchi O; Petrides M; Mejia-Constain B; Strafella AP
Brain; 2007 Jan; 130(Pt 1):233-44. PubMed ID: 17121746
[TBL] [Abstract][Full Text] [Related]
4. Greater striatal responses to medication in Parkinson׳s disease are associated with better task-switching but worse reward performance.
Aarts E; Nusselein AA; Smittenaar P; Helmich RC; Bloem BR; Cools R
Neuropsychologia; 2014 Sep; 62():390-7. PubMed ID: 24912070
[TBL] [Abstract][Full Text] [Related]
5. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic modulation of motor network dynamics in Parkinson's disease.
Michely J; Volz LJ; Barbe MT; Hoffstaedter F; Viswanathan S; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
Brain; 2015 Mar; 138(Pt 3):664-78. PubMed ID: 25567321
[TBL] [Abstract][Full Text] [Related]
7. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.
Gotham AM; Brown RG; Marsden CD
Brain; 1988 Apr; 111 ( Pt 2)():299-321. PubMed ID: 3378138
[TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
[TBL] [Abstract][Full Text] [Related]
9. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: the role of rule reconfiguration.
Kehagia AA; Barker RA; Robbins TW
J Neuropsychol; 2014 Mar; 8(1):53-74. PubMed ID: 23279799
[TBL] [Abstract][Full Text] [Related]
11. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease.
van Wouwe NC; Ridderinkhof KR; Band GP; van den Wildenberg WP; Wylie SA
Neuropsychologia; 2012 Apr; 50(5):583-91. PubMed ID: 22223079
[TBL] [Abstract][Full Text] [Related]
12. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
14. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
15. Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson's disease: A randomized cross-over trial.
Vitorio R; Stuart S; Giritharan A; Quinn J; Nutt JG; Mancini M
Parkinsonism Relat Disord; 2021 May; 86():10-14. PubMed ID: 33813359
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
[TBL] [Abstract][Full Text] [Related]
18. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
Broussolle E; Dentresangle C; Landais P; Garcia-Larrea L; Pollak P; Croisile B; Hibert O; Bonnefoi F; Galy G; Froment JC; Comar D
J Neurol Sci; 1999 Jul; 166(2):141-51. PubMed ID: 10475108
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease.
Weiss D; Klotz R; Govindan RB; Scholten M; Naros G; Ramos-Murguialday A; Bunjes F; Meisner C; Plewnia C; Krüger R; Gharabaghi A
Brain; 2015 Mar; 138(Pt 3):679-93. PubMed ID: 25558877
[TBL] [Abstract][Full Text] [Related]
20. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
